The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The In-Vitro Lung Model Market During The Forecast Period 2026–2030?
The in-vitro lung model market size has experienced significant growth in recent years. This market is projected to expand from $0.54 billion in 2025 to $0.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 21.0%. Historically, this growth can be ascribed to several factors, including the limitations of animal models in respiratory research, the longstanding reliance on two-dimensional lung cell cultures, increasing activity in respiratory disease research, a surge in academic lung biology research, and the early adoption of organoid-based research methodologies.
The in-vitro lung model market is projected for significant expansion in the coming years, reaching a valuation of $1.29 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 18.6%. This anticipated growth during the forecast period is driven by several factors, including a heightened demand for predictive preclinical lung models, a stronger emphasis on minimizing animal testing, the broadening of respiratory drug development pipelines, increased investment in sophisticated in-vitro research instruments, and the need for more physiologically relevant lung disease models. Key trends anticipated over this period encompass the wider acceptance of three-dimensional lung models in pharmaceutical research, the expanding application of lung-on-a-chip platforms for disease modeling, an increasing preference for human-relevant in-vitro lung testing solutions, the broader utilization of in-vitro lung models in toxicology and safety assessments, and their enhanced integration into preclinical research pipelines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp
What Underlying Factors Are Accelerating The Growth Of The In-Vitro Lung Model Market?
A projected expansion of the in vitro lung model market is anticipated, driven by the rising number of clinical studies. These studies are research investigations performed to assess the safety, efficacy, and results of novel medical treatments, pharmaceuticals, or diagnostic instruments in human subjects. The growing volume of clinical studies stems from escalating healthcare requirements, a heightened need for sophisticated medical interventions, and the quest for groundbreaking answers to intricate health issues. The in vitro lung model market aids clinical research through the provision of controlled systems facilitating drug screening, toxicity assessment, disease simulation, and the examination of biological responses specific to the lungs. As an illustration, data from ClinicalTrials.gov, a US-based clinical trial registry, indicated in January 2024 that a total of 477,230 clinical trials were registered worldwide by the close of 2023, showing an increase from the 437,508 trials documented in 2022. Consequently, the expansion in clinical studies acts as a primary catalyst for the in vitro lung model market.
What Market Segments Are Evaluated Within The In-Vitro Lung Model Market?
The in-vitro lung model market covered in this report is segmented –
1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures, Co-cultures
2) By Three-Dimensional (3D) Model: Spheroids, Organoids, Lung-On-A-chip Models
What Industry Trends Are Redefining The In-Vitro Lung Model Market?
Leading companies in the in vitro lung model market are concentrating on developing sophisticated 3D respiratory tissue models to boost physiological accuracy, enhance predictive precision, and reinforce preclinical testing capabilities. A 3D respiratory tissue model represents a laboratory-cultivated three-dimensional structure composed of primary or specialized respiratory cells grown in conditions that allow them to replicate the architecture and function of human airway tissues, including mucus generation, ciliary motion, and barrier integrity. For instance, in April 2023, MatTek Corporation, a US-based biotechnology company, unveiled EpiNasal, which is a 3D respiratory tissue model developed from primary human nasal epithelial cells that mimics functional aspects of nasal epithelium such as goblet cells, active tight junctions, and beating cilia, thereby providing researchers with a highly pertinent platform for assessing the effects of pharmaceuticals, chemicals, pathogens, and consumer products on human respiratory tissues.
Who Are The Top Market Participants Influencing The In-Vitro Lung Model Market?
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Epithelix, STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, Hesperos Inc., SynVivo Inc., VITROCELL Systems GmbH
Read the full in-vitro lung model market report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Which Region Is Projected To Dominate The In-Vitro Lung Model Market During The Forecast Period?
North America was the largest region in the in-vitro lung model market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored In-Vitro Lung Model Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15837&type=smp
Browse Through More Reports Similar to the Global In-Vitro Lung Model Market 2026, By The Business Research Company
In Vitro Lung Model Market Report 2026
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Artificial Lung Market Report 2026
https://www.thebusinessresearchcompany.com/report/artificial-lung-global-market-report
Pulmonary Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model